Saratoga, California -- Medical device technology company CapsoVision has received $4.6 million in new equity venture capital funding, according to an SEC regulatory filing.
CapsoVision has developed CapsoCam, a capsule-based device that helps gastroenterologists achieve better outcomes with greater comfort for their patients.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of nine investors participated in the offering.
CapsoVision is still seeking $10.4 million in additional equity investment, according to the filing.